2017年の業績 原著
- 1)
- Ikezaki T, Suzuki K, Kambara K, Inomata M, Okazawa S, Kajiura S, Miwa T, Tanabe K, Kashii T. Relationship between Carnitine Pharmacokinetics and Fatigue in Patients Treated with Cisplatin-Containing Chemotherapy. Oncol Res Treat. 2017 Feb;40(1-2):42-45.
- 2)
- Fujinami H，Kajiura S，Nishikawa J，Ando T，Sugiyama T. The influence of duodenally-delivered Shakuyakukanzoto (Shao Yao Gan Cao Tang) on duodenal peristalsis during endoscopic retrograde cholangiopancreatography: a randomised controlled trial. Chin Med. 2017 Jan 9; 12: 3.
- 3)
- Mihara H，Suzuki N，Muhammad JS，Nanjo S，Ando T，Fujinami H，Kajiura S，Hosokawa A，Sugiyama T. Transient receptor potential vanilloid 4 (TRPV4) silencing in Helicobacter pylori-infected human gastric epithelium. Helicobacter. 2017 Apr; 22(2). Epub 2016 Sep 30.
- 4)
- Hosokawa A，Ando T，Ogawa K，Ueda A，Yoshita H，Mihara H，Fujinami H，Kajiura S，Yabushita K，Horikawa N，Kobayashi Y，Yoshioka A，Origasa H，Sugiyama T. Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer. Am J Clin Oncol. 2017 Sep 19.[Epub ahead of print]
- 5)
- Inomata M, Tanaka H, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Yamada T, Miwa T, Hayashi R, Tobe K. Clinical course after initiation of nivolumab therapy in patients with EGFR-mutated Non-small cell lung cancer with or without Pd-L1 expression. Oncology and Therapy. 2017 Oct 20;5(2):181-185.
- 6)
- Taka C, Hayashi R, Shimokawa K, Tokui K, Okazawa S, Kambara K, Inomata M, Yamada T, Matsui S, Tobe K. SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017 Nov 3;12:3237-3244.
- 7)
- 猪又峰彦，田中宏明，下川一生，徳井宏太郎，岡澤成祐，高 千紘，神原健太，今西信悟，山田 徹，三輪敏郎，林 龍二，松井祥子，菓子井達彦，本間崇浩，野村邦紀，土岐善紀，戸邉一之．後ろ向き観察研究による非小細胞肺癌術後再発例における局所または全身治療実施後の臨床経過の評価．癌と化学療法，2017 Sep；44(9)：767-770．
